Molecular Oncology in Breast Cancer
In the present period, sub-atomic oncology has cleared its way in the exhaustive cancer care and is assuming a critical part, particularly in the disclosure of novel cell, focuses to misuse for novel focused on medications, new biomarkers distinguishing proof for early malignancy location, and to give a superior characterization of tumors for guess and treatment choice. The sub-atomic premise of breast carcinogenesis including hereditary and epigenetic occasions that outcome in the changed articulation of various qualities is yet not completely comprehended and still should be deciphered more, which mirrors the unpredictability of the sub-atomic modifications that portray tumor cells.
The majority of the breast malignancy genome is specifically subdued; around, 3-5% of qualities are dynamic in a specific tumor cell that is administered by the direction of quality articulation, for the most part at the level of translation. Cell bother (change) causes changes in quality articulation that outcome in the declaration of many quality items and the concealment of others. Consequently, sub-atomic heterogeneity is created that describes a tumor of various histology and adds to the changeability in result and reaction to treatment. Further, huge changeability additionally exists for tumors of a particular histologic write. Till as of late, in breast disease administration, clinical choices, visualizations, and expectations were constructed exclusively upon histopathologic investigation, or one or little quantities of qualities or their appearances (proteins) in the tumor tissue, yet this approach has been deficient and neglected to create exact conclusions. There has been a rise of the new worldview called "Genomic Paradigm," a move from the seniority "Clinico-Pathological Paradigm"
- Effects of proton radiation on foetus
- Pathological anatomy of early stage breast cancer
- Physics of accelerated partial breast irradiation
- Brachytherapy technique
- Bio engineering
Related Conference of Molecular Oncology in Breast Cancer
June 13-14, 2022
21st International Conference on Cancer Biology and Cell Science
Amsterdam, Netherlands
August 22-23, 2022
2nd International Conference on Biomarkers and Clinical Research
Barcelona, Spain
September 12-12, 2022
36th International Conference on Cancer Science & Therapy
Amsterdam, Netherlands
September 23-24, 2022
17th World Congress on Biomarkers, Cancer Therapy & Clinical Research
Vancouver, Canada
September 24-25, 2022
3rd International Conference on Oncodiagnostics and Cancer Research
Vancouver, Canada
Molecular Oncology in Breast Cancer Conference Speakers
Recommended Sessions
- Cancer Therapeutics
- Breast and Cervical Cancer Screening
- Breast Cancer Biology
- Breast Reconstruction (Onco-plastic Surgery)
- Breastfeeding and Breast Cancer
- Cancer Biomarkers
- Cancer Epigenomics: Beyond Genomics
- Cancer Genomics
- Cancer Vaccination
- Cervical Cancer Biology
- Chemotherapy and Cancer
- Complementary and Alternative Medicine for cancer
- Gynaecologic Oncology
- HPV and Pregnancy
- Immunological Approaches to Cancer Therapy
- Male Breast Cancer
- Molecular Oncology in Breast Cancer
- Nanotechnology / Nano-medicines in Cancer Treatment
- Women’s Health and Contraception
Related Journals
Are you interested in
- Cancer Metastasis - Cell Signaling 2022 (Canada)
- Advanced Therapies in Cancer - Cancer Biology 2022 (Netherlands)
- Advancement in the field of cancer - Cancer Biology 2022 (Netherlands)
- Advances in Cancer Detection - Euro Oncology 2022 (France)
- Advances in epigenetic technology - Epigenetics 2022 (Austria)
- Alternative Treatments and Therapeutics - Cancer Science 2022 (Italy)
- Anaemia and Blood Disorders - Cancer Biology 2022 (Netherlands)
- Antibody-based Therapeutics Against Cancer - Frontiers In Cancer 2022 (Japan)
- Anticancer drug - Preventive Oncology 2022 (Germany)
- Antineoplastic drugs - RADIOCANCER - 2022 (France)
- Bioinformatics and biostatics in epigenetic disease markers and targets - Epigenetics 2022 (Austria)
- Biology of Cancer - Global Cancer 2022 (Australia)
- Biomarkers - Biomarkers 2022 (Canada)
- Biomarkers Case Reports - Biomarkers 2022 (Canada)
- Biomarkers for Disorders - Biomarkers 2022 (Canada)
- Biomarkers in Clinical Research and Development - Biomarkers 2022 (Canada)
- Biomarkers in Drug Discovery - Biomarkers 2022 (Canada)
- Biomarkers in Market - Biomarkers 2022 (Canada)
- Biomarkers in Microbial Infections - Biomarkers 2022 (Canada)
- Biomarkers in Nanoscience - Biomarkers 2022 (Canada)
- Biomarkers in Toxicology - Biomarkers 2022 (Canada)
- Biomarkers of Exposure Response and Susceptibility - Biomarkers 2022 (Canada)
- Biomarkers: Entrepreneur Investments Meet - Biomarkers 2022 (Canada)
- Bladder Cancer - Euro Oncology 2022 (France)
- Blood Cancer and Bone Cancer - Oncology And Hematology 2022 (Singapore)
- Bone Marrow Transplantation and Surgery - Cancer Biology 2022 (Netherlands)
- Brain Cancer - Euro Oncology 2022 (France)
- Brain tumor - Preventive Oncology 2022 (Germany)
- Brain Tumor - Epigenetics 2022 (Austria)
- Breast Cancer - breastcancercongress 2022 (Canada)
- Breast Cancer - Cancer Science 2022 (Italy)
- Breast Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Breast cancer - CANCER THERAPY MEETING 2022 (Australia)
- Breast cancer and cervical cancer - Global Cancer 2022 (Australia)
- Breast Cancer and Genetics - breastcancercongress 2022 (Canada)
- Breast cancer and the Immune system - breastcancercongress 2022 (Canada)
- Breast Cancer Clinical Trials - breastcancercongress 2022 (Canada)
- Breast cancer detection, Prevention and diagnosis - Euro Oncology 2022 (France)
- Breast Cancer Nursing - breastcancercongress 2022 (Canada)
- Breast Cancer Recurrence - breastcancercongress 2022 (Canada)
- Breast Cancer Research - Frontiers In Cancer 2022 (Japan)
- Breast Cancer Risk Factors - breastcancercongress 2022 (Canada)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - World Oncology 2022 (UAE)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - Women Oncology 2022 (Canada)
- Breast Implants - breastcancercongress 2022 (Canada)
- Breast Microcalcifications - breastcancercongress 2022 (Canada)
- Breast Oncology - Oncology And Hematology 2022 (Singapore)
- Cancer - Cancer Biology 2022 (Netherlands)
- Cancer & Therapeutics - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer and Stem Cell Therapy - World Cancer 2022 (Italy)
- Cancer Awareness and Survival - World Cancer 2022 (Italy)
- Cancer Awareness and Survival - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Bioinformatics - Cancer and Care 2022 (USA)
- Cancer Bioinformatics - Preventive Oncology 2022 (Germany)
- Cancer Biology - Women Oncology 2022 (Canada)
- Cancer Biology - World Oncology 2022 (UAE)
- Cancer Biology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Biology - RADIOCANCER - 2022 (France)
- Cancer Biomarkers - World Oncology 2022 (UAE)
- Cancer Biomarkers - World Cancer 2022 (Italy)
- Cancer Biomarkers - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Biomarkers - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Biomarkers - Preventive Oncology 2022 (Germany)
- Cancer Biomarkers - Cell Signaling 2022 (Canada)
- Cancer Biomarkers - Biomarkers 2022 (Canada)
- Cancer Biomarkers - Cancer Science 2022 (Italy)
- Cancer Biomarkers - Frontiers In Cancer 2022 (Japan)
- Cancer Biomarkers - Women Oncology 2022 (Canada)
- Cancer Biomarkers - Cancer and Care 2022 (USA)
- Cancer Biopsy - Cancer Science 2022 (Italy)
- Cancer Biopsy - World Cancer 2022 (Italy)
- Cancer Cell Biology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Cell Biology and Cancer Biomarker - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Cell Biology and Genetics - World Cancer 2022 (Italy)
- Cancer Cell Signaling - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Cell Signalling & Pathways - Frontiers In Cancer 2022 (Japan)
- Cancer Chemotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Chemotherapy - World Cancer 2022 (Italy)
- Cancer Control & Population Health - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Development - Women Oncology 2022 (Canada)
- Cancer Development - World Oncology 2022 (UAE)
- Cancer Diagnosis and Screening - Cancer Science 2022 (Italy)
- Cancer Diagnostics: From Research to Clinical Practice - Frontiers In Cancer 2022 (Japan)
- Cancer Drugs - Women Oncology 2022 (Canada)
- Cancer Drugs - World Oncology 2022 (UAE)
- Cancer Epidemiology - Frontiers In Cancer 2022 (Japan)
- Cancer Epidemiology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Epidemiology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Epidemiology - Global Cancer 2022 (Australia)
- Cancer Epidemiology - Cancer Science 2022 (Italy)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Women Oncology 2022 (Canada)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - World Oncology 2022 (UAE)
- Cancer Epigenetics - Cancer Science 2022 (Italy)
- Cancer Genetics - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Genetics - Cell Signaling 2022 (Canada)
- Cancer Genetics - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Genetics & Epigenetics - Frontiers In Cancer 2022 (Japan)
- Cancer Genetics and Epigenetics - Cancer and Care 2022 (USA)
- Cancer Genomics & Metabolomics - Cancer Biology 2022 (Netherlands)
- Cancer Health Disparities - Cancer Biology 2022 (Netherlands)
- Cancer Health Disparities - Women Oncology 2022 (Canada)
- Cancer Health Disparities - World Oncology 2022 (UAE)
- Cancer Imaging Techniques - Global Cancer 2022 (Australia)
- Cancer Immunology & Immunotherapy - Cancer and Care 2022 (USA)
- Cancer Immunology & Immunotherapy - Frontiers In Cancer 2022 (Japan)
- Cancer Immunology & Immunotherapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Immunotherapy & Vaccines - RADIOCANCER - 2022 (France)
- Cancer Management and Prevention - Cancer Science 2022 (Italy)
- Cancer Metabolism - Frontiers In Cancer 2022 (Japan)
- Cancer Metabolomics - World Cancer 2022 (Italy)
- Cancer Metastasis - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Metastasis - World Cancer 2022 (Italy)
- Cancer Metastasis - Cancer and Care 2022 (USA)
- Cancer Metastasis - Cancer Science 2022 (Italy)
- Cancer Mode of Existence - Preventive Oncology 2022 (Germany)
- Cancer Nanotechnology - World Cancer 2022 (Italy)
- Cancer Nanotechnology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Nanotechnology - Global Cancer 2022 (Australia)
- Cancer Nanotechnology - Preventive Oncology 2022 (Germany)
- Cancer Nanotechnology - Cancer Science 2022 (Italy)
- Cancer Palliative Care & Survivors - Cancer Biology 2022 (Netherlands)
- Cancer Pathophysiology - Global Cancer 2022 (Australia)
- Cancer Pathophysiology - Preventive Oncology 2022 (Germany)
- Cancer Pharmacology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Pharmacology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Pharmacology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Pharmacology - World Cancer 2022 (Italy)
- Cancer Pharmacology - Cancer Science 2022 (Italy)
- Cancer Pharmacology & Cytopathology - Cell Signaling 2022 (Canada)
- Cancer Prevention - Frontiers In Cancer 2022 (Japan)
- Cancer Prevention & Research - CANCER THERAPY MEETING 2022 (Australia)
- Cancer prevention and Care - Cancer and Care 2022 (USA)
- Cancer Prevention and Research - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Prevention and Research - World Cancer 2022 (Italy)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - World Oncology 2022 (UAE)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Women Oncology 2022 (Canada)
- Cancer Prognosis - Global Cancer 2022 (Australia)
- Cancer Rehabilitation - RADIOCANCER - 2022 (France)
- Cancer Risk Factors - Women Oncology 2022 (Canada)
- Cancer Risk Factors - World Oncology 2022 (UAE)
- Cancer Scenario - Oncology And Hematology 2022 (Singapore)
- Cancer Science - Women Oncology 2022 (Canada)
- Cancer Science - World Oncology 2022 (UAE)
- Cancer Science - Cancer Science 2022 (Italy)
- Cancer Science - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Screening - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer screening - Cancer and Care 2022 (USA)
- Cancer Screening & Diagnosis - Global Cancer 2022 (Australia)
- Cancer Stem Cell Therapy - Cancer and Care 2022 (USA)
- Cancer Stem Cells - Frontiers In Cancer 2022 (Japan)
- Cancer Stem cells - Cell Signaling 2022 (Canada)
- Cancer Stem Cells - Women Oncology 2022 (Canada)
- Cancer Stem Cells - World Oncology 2022 (UAE)
- Cancer Therapeutics - Cell Signaling 2022 (Canada)
- Cancer Therapeutics and Novel Approaches - Preventive Oncology 2022 (Germany)
- Cancer Therapy - Cancer Science 2022 (Italy)
- Cancer Therapy - Preventive Oncology 2022 (Germany)
- Cancer Therapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Therapy - Oncology And Hematology 2022 (Singapore)
- Cancer Therapy & Treatments - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Therapy & Treatments - Frontiers In Cancer 2022 (Japan)
- Cancer Treatment - Women Oncology 2022 (Canada)
- Cancer Treatment - World Oncology 2022 (UAE)
- Cancer Vaccines - Frontiers In Cancer 2022 (Japan)
- Cancer Vaccines - Women Oncology 2022 (Canada)
- Cancer Vaccines - Cancer and Care 2022 (USA)
- Cancer Vaccines - World Oncology 2022 (UAE)
- Cancer Vaccines - Global Cancer 2022 (Australia)
- Cancer Vaccines - Cell Signaling 2022 (Canada)
- Cancer Vaccines - World Cancer 2022 (Italy)
- Cancer: Lifestyle Connection and Nutrition - World Cancer 2022 (Italy)
- Cancer: Psychological and Social Aspects - World Cancer 2022 (Italy)
- Cancer: Psychological Aspects - WOMEN ONCOLOGY 2022 (Thailand)
- Cancers of specific organs - RADIOCANCER - 2022 (France)
- Carcinogenesis. - Frontiers In Cancer 2022 (Japan)
- Carcinogens in cosmetics - RADIOCANCER - 2022 (France)
- Cardio Oncology - Women Oncology 2022 (Canada)
- Cardio Oncology - World Oncology 2022 (UAE)
- Cause of Cancer - Global Cancer 2022 (Australia)
- Cell & Gene Therapy - Cell Signaling 2022 (Canada)
- Cell Biology - Cell Signaling 2022 (Canada)
- Cell biology of cancer - Preventive Oncology 2022 (Germany)
- Cell Metabolism - Cell Signaling 2022 (Canada)
- Cell Signaling - Cell Signaling 2022 (Canada)
- Cell-Based Therapy - Cancer Biology 2022 (Netherlands)
- Cervical Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Chemical Biology - Cancer Biology 2022 (Netherlands)
- Chemotherapy - WOMEN ONCOLOGY 2022 (Thailand)
- Chromatin analysis - Epigenetics 2022 (Austria)
- Chromatin domains and structure - Epigenetics 2022 (Austria)
- Circulating Tumor Cell (CTC) - Women Oncology 2022 (Canada)
- Circulating Tumor Cell (CTC) - World Oncology 2022 (UAE)
- Circulating Tumor Cells - Frontiers In Cancer 2022 (Japan)
- Clinical Advances in Liver Diseases - GASTRO CANCER 2022 (Netherlands)
- Clinical Research & Clinical Trials of cancer - Global Cancer 2022 (Australia)
- Clinical Trials of Cancer - Cancer Biology 2022 (Netherlands)
- Coagulation - Oncology And Hematology 2022 (Singapore)
- Colorectal Cancer - Euro Oncology 2022 (France)
- Colorectal Cancer Progression - Frontiers In Cancer 2022 (Japan)
- Complementary & Alternative Methods and Cancer - CANCER THERAPY MEETING 2022 (Australia)
- Complementary and Alternative Methods and Cancer - World Cancer 2022 (Italy)
- Computational Analysis of Cancer - Frontiers In Cancer 2022 (Japan)
- Computational modeling - Epigenetics 2022 (Austria)
- Computational Oncology - Cancer Biology 2022 (Netherlands)
- Computational Oncology - Cancer Biology 2022 (Netherlands)
- Covid-19 and GI Cancer Management - GASTRO CANCER 2022 (Netherlands)
- COVID-19 and its impact on Cancer patients - Frontiers In Cancer 2022 (Japan)
- Current Research Concepts in Biomarkers - Biomarkers 2022 (Canada)
- Dermatological Cancer - Oncology And Hematology 2022 (Singapore)
- Diagnosis & Screening of Cancer - Cancer Biology 2022 (Netherlands)
- Digestive Disorders - GASTRO CANCER 2022 (Netherlands)
- Diverticular Disease - GASTRO CANCER 2022 (Netherlands)
- DNA & RNA sequencing - Epigenetics 2022 (Austria)
- Drug Resistance - Frontiers In Cancer 2022 (Japan)
- Endometrial Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Environmental Epigenetic Factor - Epigenetics 2022 (Austria)
- Epidemiology of Cancer - Cancer Biology 2022 (Netherlands)
- Epigenetics - Epigenetics 2022 (Austria)
- Epigenetics - Cancer Biology 2022 (Netherlands)
- Epigenetics and epigenomics - Epigenetics 2022 (Austria)
- Epigenetics and stem cell reprogramming - Epigenetics 2022 (Austria)
- Epigenetics in bacteria - Epigenetics 2022 (Austria)
- Epigenetics in cancer - Preventive Oncology 2022 (Germany)
- Epigenetics in psychology and psychiatry - Epigenetics 2022 (Austria)
- Epigenetics Reproductive Health - Epigenetics 2022 (Austria)
- Epigenome and transcriptome editing - Epigenetics 2022 (Austria)
- Fragment analysis - Epigenetics 2022 (Austria)
- Functional Genomics and Cytogenetic Biomarkers - Biomarkers 2022 (Canada)
- Functional Transcriptomics and Profiling Techniques - Biomarkers 2022 (Canada)
- Functions and consequences: development and transgenerational - Epigenetics 2022 (Austria)
- Gallbladder and Biliary Tract Diseases - GASTRO CANCER 2022 (Netherlands)
- Gastroenterology - GASTRO CANCER 2022 (Netherlands)
- Gastroesophageal Reflux Malady - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal cancer - Preventive Oncology 2022 (Germany)
- Gastrointestinal Cancer - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Disorders - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Endoscopy - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Immunology - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Oncology - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Pathology - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Pharmacology - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Radiology - GASTRO CANCER 2022 (Netherlands)
- Gastrointestinal Therapeutics - GASTRO CANCER 2022 (Netherlands)
- Genetic Mutations Of Cancer - Women Oncology 2022 (Canada)
- Genetic Mutations Of Cancer - World Oncology 2022 (UAE)
- Genomes editing - Epigenetics 2022 (Austria)
- Gerson therapy - Preventive Oncology 2022 (Germany)
- Gynaecological cancers - RADIOCANCER - 2022 (France)
- Gynecologic Oncology - Women Oncology 2022 (Canada)
- Gynecologic Oncology - World Oncology 2022 (UAE)
- Hemato Immunology & Stem Cell Research - Cancer Biology 2022 (Netherlands)
- Hematological Cancers - RADIOCANCER - 2022 (France)
- Hematological Tumors - Frontiers In Cancer 2022 (Japan)
- Hematology- Oncology - Cancer Science 2022 (Italy)
- Hepato Radiology - GASTRO CANCER 2022 (Netherlands)
- Immune Responses & DNA Repair – Cancer Fields - Frontiers In Cancer 2022 (Japan)
- Immunotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Inflammatory Bowel Disease: Types, Causes, and Risk Factors - GASTRO CANCER 2022 (Netherlands)
- Innovative Cancer Science: Translating Biology to Medicine - Frontiers In Cancer 2022 (Japan)
- Integrative care - WOMEN ONCOLOGY 2022 (Thailand)
- Interventional Radiology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Irritable Bowel Syndrome - GASTRO CANCER 2022 (Netherlands)
- Key role of Pathology in cancer - Euro Oncology 2022 (France)
- Lifestyle and Nutrition for Cancer - Cancer and Care 2022 (USA)
- Liver Cancer - CANCER THERAPY MEETING 2022 (Australia)
- Liver Cirrhosis - GASTRO CANCER 2022 (Netherlands)
- Liver Diseases and Hepatitis - GASTRO CANCER 2022 (Netherlands)
- Lung Cancer - Preventive Oncology 2022 (Germany)
- Lung Cancer - Frontiers In Cancer 2022 (Japan)
- Lung Cancer - Oncology And Hematology 2022 (Singapore)
- Lung Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Magnetic Resonance Imaging (MRI) - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Measurement and mapping of genomic - Epigenetics 2022 (Austria)
- Medical Imaging Technology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Metastatic Cancer - Preventive Oncology 2022 (Germany)
- Microbiota and Diseases - GASTRO CANCER 2022 (Netherlands)
- MicroRNA and Cancer - Global Cancer 2022 (Australia)
- Mylenoma - RADIOCANCER - 2022 (France)
- Nanopore Sequencing of Cancer Genomics - Frontiers In Cancer 2022 (Japan)
- Nanotechnology In Cancer Treatment - World Oncology 2022 (UAE)
- Nanotechnology In Cancer Treatment - Women Oncology 2022 (Canada)
- Neonatal and Pediatric Oncology - World Cancer 2022 (Italy)
- Neonatal And Pediatric Oncology - Women Oncology 2022 (Canada)
- Neonatal And Pediatric Oncology - World Oncology 2022 (UAE)
- Neuro Gastroenterology - GASTRO CANCER 2022 (Netherlands)
- Neuro-oncology - Preventive Oncology 2022 (Germany)
- Neuro-oncology: focuses on cancers of brain - Epigenetics 2022 (Austria)
- Neurological Cancer - Oncology And Hematology 2022 (Singapore)
- Neuroradiology and Neuro Oncology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Next Generation Cancer Models - Frontiers In Cancer 2022 (Japan)
- Nucleosome positioning - Epigenetics 2022 (Austria)
- Nursing Oncology - Oncology And Hematology 2022 (Singapore)
- Nutritional Biomarkers - Biomarkers 2022 (Canada)
- Omics Technologies in Biomarkers Discovery and Validation - Biomarkers 2022 (Canada)
- Oncogenomics - Cancer Science 2022 (Italy)
- Oncologists: Biomarkers - Biomarkers 2022 (Canada)
- Oncology - Epigenetics 2022 (Austria)
- Oncology - WOMEN ONCOLOGY 2022 (Thailand)
- Oncology nursing - Preventive Oncology 2022 (Germany)
- Oncology Nursing - Women Oncology 2022 (Canada)
- Oncology Nursing - World Oncology 2022 (UAE)
- Oncology Nursing - WOMEN ONCOLOGY 2022 (Thailand)
- Oncology Nursing and Care - World Cancer 2022 (Italy)
- Oncology Nursing and Care - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Oncology Nursing and Care - Cancer Science 2022 (Italy)
- Oncology Research - Women Oncology 2022 (Canada)
- Oncology Research - World Oncology 2022 (UAE)
- Oncology: Sub-Specialities - CANCER THERAPY MEETING 2022 (Australia)
- Oncology: Sub-Specialties - World Cancer 2022 (Italy)
- Ophthalmic Oncology - Euro Oncology 2022 (France)
- Organ Specific Cancer - Cancer and Care 2022 (USA)
- Organ Specific Cancer - Women Oncology 2022 (Canada)
- Organ Specific Cancer - World Oncology 2022 (UAE)
- Organ-Defined Cancers - World Cancer 2022 (Italy)
- Organ-Defined Cancers - CANCER THERAPY MEETING 2022 (Australia)
- Organ-Defined Cancers - Frontiers In Cancer 2022 (Japan)
- Organic Specific Cancer - Cancer Science 2022 (Italy)
- Oropharyngeal Cancer - Oncology And Hematology 2022 (Singapore)
- Ovarian Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Pancreatic Cancer and Colorectal Cancer - Oncology And Hematology 2022 (Singapore)
- Pancreatic Diseases - GASTRO CANCER 2022 (Netherlands)
- Pathology In Cancer - Cancer and Care 2022 (USA)
- Pathophysiology of Cancer - Oncology And Hematology 2022 (Singapore)
- Pediatric / Neonatal Gastroenterology and Nutrition - GASTRO CANCER 2022 (Netherlands)
- Personalized Medicine and Data Analysis - Biomarkers 2022 (Canada)
- Phases And Types Of Clinical Trails - Women Oncology 2022 (Canada)
- Phases And Types Of Clinical Trails - World Oncology 2022 (UAE)
- Plants Against Cancer - Preventive Oncology 2022 (Germany)
- Precision Cancer Medicine & Oncology - CANCER THERAPY MEETING 2022 (Australia)
- Precision Medicine And Immuno-Oncology - Women Oncology 2022 (Canada)
- Precision Medicine And Immuno-Oncology - World Oncology 2022 (UAE)
- Protein interaction analysis - Epigenetics 2022 (Austria)
- Protein Signaling & Neuronal Signaling - Cell Signaling 2022 (Canada)
- Pulmonary Oncology - Women Oncology 2022 (Canada)
- Pulmonary Oncology - World Oncology 2022 (UAE)
- Radiation & Chemotherapy - Cell Signaling 2022 (Canada)
- Radiation oncology - Preventive Oncology 2022 (Germany)
- Radiation Oncology - Women Oncology 2022 (Canada)
- Radiation Oncology - World Oncology 2022 (UAE)
- Radiation Oncology - Frontiers In Cancer 2022 (Japan)
- Radiation Oncology - Cancer Biology 2022 (Netherlands)
- Radiation Oncology - Cancer Science 2022 (Italy)
- Radiation Oncology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Radiation Therapy - WOMEN ONCOLOGY 2022 (Thailand)
- Radiation Therapy and its side effects - Cancer and Care 2022 (USA)
- Radiation Therapy for Cancer - RADIOCANCER - 2022 (France)
- Radiology Trends and Technology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Radiology/Cancer Imaging - Frontiers In Cancer 2022 (Japan)
- Radiopharmaceuticals - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Radiotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Radiotherapy and Chemotherapy - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Reconstruction of breast cancer - breastcancercongress 2022 (Canada)
- Renal Cancer and Hepatocellular Cancer - Oncology And Hematology 2022 (Singapore)
- Reproductive Cancers - Oncology And Hematology 2022 (Singapore)
- Retinoblastoma - RADIOCANCER - 2022 (France)
- RNA transcripts, MicroRNAs, mRNA, and sRNA - Epigenetics 2022 (Austria)
- Robotic surgery for cancer treatment - Preventive Oncology 2022 (Germany)
- Screening tests - Preventive Oncology 2022 (Germany)
- Signal Transduction - Cell Signaling 2022 (Canada)
- Signaling Pathways & Diseases - Cell Signaling 2022 (Canada)
- Single-cell and Spatial Multiomics in Cancer Research - Frontiers In Cancer 2022 (Japan)
- Skin Cancer - Preventive Oncology 2022 (Germany)
- Skin Cancer - Cancer Science 2022 (Italy)
- Skin cancers - Frontiers In Cancer 2022 (Japan)
- Solid Tumors - Frontiers In Cancer 2022 (Japan)
- Stem Cell Therapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Stem cell Therapy - Cancer Science 2022 (Italy)
- Structural inheritance - Epigenetics 2022 (Austria)
- Surgeries involved in Breast Cancer - breastcancercongress 2022 (Canada)
- Surgical Oncology - Cancer Science 2022 (Italy)
- Surgical oncology - Preventive Oncology 2022 (Germany)
- Surgical Oncology - Frontiers In Cancer 2022 (Japan)
- Targeted Cancer Therapy - Cancer Science 2022 (Italy)
- Techniques to Maximize Biomarker Identification - Biomarkers 2022 (Canada)
- The Application of Clinical Proteomics for Precision Oncology - Frontiers In Cancer 2022 (Japan)
- Treating Breast Cancer with Chemotherapy - breastcancercongress 2022 (Canada)
- Treatment of Cancer - Cancer Biology 2022 (Netherlands)
- Treatments of Cancer - Global Cancer 2022 (Australia)
- Tumor Biology - Cancer Science 2022 (Italy)
- Tumor Heterogeneity and Cancer Metastasis - Frontiers In Cancer 2022 (Japan)
- Tumor Immunology - Cancer Science 2022 (Italy)
- Tumor virology - Preventive Oncology 2022 (Germany)
- Tumor Virology - Cancer Science 2022 (Italy)
- Tumor Virology, Immunology and Cellular Pathology - World Cancer 2022 (Italy)
- Tumors heterogeneity - Preventive Oncology 2022 (Germany)
- Tumour Microenvironment - Frontiers In Cancer 2022 (Japan)
- Tumour screening and clinical management - RADIOCANCER - 2022 (France)
- Types of Cancer & their Management - Cancer Biology 2022 (Netherlands)
- Types Of Cancers - Women Oncology 2022 (Canada)
- Types Of Cancers - World Oncology 2022 (UAE)
- Veterinary Oncology - Women Oncology 2022 (Canada)
- Veterinary Oncology - World Oncology 2022 (UAE)